ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,929 | +291.1% | 109 | +419.0% | 0.00% | – |
| Q2 2023 | $749 | -34.5% | 21 | -53.3% | 0.00% | – |
| Q1 2023 | $1,143 | -90.9% | 45 | -85.4% | 0.00% | – |
| Q4 2022 | $12,492 | -16.7% | 308 | -31.9% | 0.00% | -100.0% |
| Q3 2022 | $15,000 | +66.7% | 452 | +82.3% | 0.00% | – |
| Q2 2022 | $9,000 | +800.0% | 248 | +755.2% | 0.00% | – |
| Q1 2022 | $1,000 | -87.5% | 29 | -77.0% | 0.00% | – |
| Q4 2021 | $8,000 | +14.3% | 126 | +5.0% | 0.00% | – |
| Q3 2021 | $7,000 | -46.2% | 120 | -20.5% | 0.00% | -100.0% |
| Q2 2021 | $13,000 | +18.2% | 151 | -12.7% | 0.00% | – |
| Q1 2021 | $11,000 | +57.1% | 173 | +92.2% | 0.00% | – |
| Q4 2020 | $7,000 | +133.3% | 90 | +40.6% | 0.00% | – |
| Q3 2020 | $3,000 | +50.0% | 64 | +52.4% | 0.00% | – |
| Q2 2020 | $2,000 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |